Bionano Genomics, Inc.
BNGO
$3.27
$0.123.81%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.86M | -3.10M | -20.13M | -44.25M | -16.22M |
| Total Depreciation and Amortization | 2.43M | 2.49M | 2.45M | 5.68M | 3.04M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.70M | -4.17M | 8.91M | 24.06M | -3.43M |
| Change in Net Operating Assets | -763.00K | 2.02M | 2.27M | 1.20M | -4.36M |
| Cash from Operations | -3.49M | -2.76M | -6.50M | -13.31M | -20.98M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -77.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.98M | -14.07M | 3.00M | -5.38M | 28.71M |
| Cash from Investing | 1.98M | -14.07M | 3.00M | -5.38M | 28.63M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 18.00M |
| Total Debt Repaid | -3.02M | -16.00K | -2.01M | -3.02M | -25.80M |
| Issuance of Common Stock | 3.09M | 13.33M | 6.72M | 10.11M | 12.17M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.40M | -2.42M | -818.00K | -1.08M | -6.35M |
| Cash from Financing | 1.47M | 10.89M | 3.89M | 6.02M | -1.98M |
| Foreign Exchange rate Adjustments | -24.00K | -9.00K | -4.00K | 24.00K | -1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -63.00K | -5.95M | 379.00K | -12.64M | 5.67M |